Перейти к содержанию

Perrigo Co plc (PRGO) stock: revenue, earnings & dividend

Perrigo Co plc (PRGO, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PRGO · NYSE Pharma & Biotech IE-

Key figures

Fiscal year
2025
Revenue
4.25 bn $
Revenue growth
-2.8 %
Revenue growth 5y (p.a.)
0.8 %
Net income
-1.43 bn $
Net margin
-33.5 %
Operating margin
-26.4 %
Earnings per share (diluted)
-10.29 $
Dividend per share
1.16 $
Payout ratio
–
Consecutive dividend years
14 years
Consecutive dividend raises
13 years
Dividend growth 5y (p.a.)
5.2 %
Total assets
8.54 bn $
Equity
2.94 bn $
Equity ratio
34.4 %
Return on equity
-48.6 %
Cash
532 m $
Operating cash flow
239 m $
Free cash flow
145 m $
Shares outstanding
138,801,872

History

Revenue by fiscal year

2016 5.28 bn $
2017 4.95 bn $
2018 4.73 bn $
2019 3.87 bn $
2020 4.09 bn $
2021 4.14 bn $
2022 4.45 bn $
2023 4.66 bn $
2024 4.37 bn $
2025 4.25 bn $

Net income by fiscal year

2016 -4.01 bn $
2017 120 m $
2018 131 m $
2019 146 m $
2020 -162.6 m $
2021 -68.9 m $
2022 -140.6 m $
2023 -12.7 m $
2024 -171.8 m $
2025 -1.43 bn $

Dividend per share

2016 0.58 $
2017 0.64 $
2018 0.76 $
2019 0.82 $
2020 0.90 $
2021 0.96 $
2022 1.04 $
2023 1.09 $
2024 1.10 $
2025 1.16 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20254.25 bn $-1.43 bn $-10.29 $1.16 $239 m $
20244.37 bn $-171.8 m $-1.25 $1.10 $363 m $
20234.66 bn $-12.7 m $-0.09 $1.09 $406 m $
20224.45 bn $-140.6 m $-1.04 $1.04 $307 m $
20214.14 bn $-68.9 m $-0.52 $0.96 $156 m $
20204.09 bn $-162.6 m $-1.19 $0.90 $636 m $
20193.87 bn $146 m $1.07 $0.82 $388 m $
20184.73 bn $131 m $0.95 $0.76 $593 m $
20174.95 bn $120 m $0.84 $0.64 $699 m $
20165.28 bn $-4.01 bn $-28.01 $0.58 $655 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)